| Serial Number | 98848976 |
| Word Mark | XEVUDY |
| Filing Date | Tuesday, November 12, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, April 7, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 29, 2025 |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of COVID-19, coronavirus disease and respiratory diseases and disorders; vaccines for prevention of COVID-19, coronavirus disease |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY GB |
| Event Date | Event Description |
| Tuesday, November 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 12, 2024 | NEW APPLICATION ENTERED |
| Saturday, March 8, 2025 | ASSIGNED TO EXAMINER |
| Saturday, March 29, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |